Henry J. Fuchs, Director at Mirati Therapeutics, Inc. (MRTX), sold 19,960 shares at $237.36 ($4.7M) on 2020-12-15, disclosed to the SEC on 2020-12-16.
Open-market sale of $4.7M MRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $230.19 | 1,218 | $280K | 6.0% |
| 2 | $230.19 | 1,218 | $280K | 6.0% |
| 3 | $232.01 | 1,399 | $325K | 7.0% |
| 4 | $232.01 | 1,399 | $325K | 7.0% |
| 5 | $233.40 | 4,461 | $1.0M | 22.4% |
| 6 | $233.40 | 4,461 |
| $1.0M |
| 22.4% |
| 7 | $234.27 | 610 | $143K | 3.1% |
| 8 | $234.27 | 610 | $143K | 3.1% |
| 9 | $235.19 | 1,821 | $428K | 9.2% |
| 10 | $235.19 | 1,821 | $428K | 9.2% |
| 11 | $237.36 | 451 | $107K | 2.3% |
| 12 | $237.36 | 451 | $107K | 2.3% |
| 13 | $237.90 | 40 | $10K | 0.2% |
| Total | $233.38 avg | 19,960 | $4.7M | 100% |
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |
| BMRN | SELL | 2020-07-22 | $16.4M | — | Filing → |